2021
DOI: 10.1093/eurpub/ckab100
|View full text |Cite
|
Sign up to set email alerts
|

Cervical cancer testing among women aged 30–49 years in the WHO European Region

Abstract: Background Screening programs play an important role in a comprehensive strategy to prevent cervical cancer, a leading cause of death among women of reproductive age. Unfortunately, there is a dearth of information about rates of cervical cancer testing, particularly in Eastern Europe and Central Asia where levels of cervical cancer are among the highest in the WHO European Region. The purpose of this article is to report on the lifetime prevalence of cervical cancer testing among females age… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Cervical cancer screening services are globally endorsed as an effective measure for preventing the second most common cancer in women. However, the utilization of these services exhibits significant disparities worldwide, with lower-income countries having a smaller share of coverage [ 6 ]. Screening coverage varies widely, with rates reported at approximately 78% in Spain and England, 98% in Finland, 65.6% in Korea, and 62% in Botswana [ 15 , 16 , 26 28 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Cervical cancer screening services are globally endorsed as an effective measure for preventing the second most common cancer in women. However, the utilization of these services exhibits significant disparities worldwide, with lower-income countries having a smaller share of coverage [ 6 ]. Screening coverage varies widely, with rates reported at approximately 78% in Spain and England, 98% in Finland, 65.6% in Korea, and 62% in Botswana [ 15 , 16 , 26 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…The Papanicolaou cervical screening method has been instrumental in preventing a substantial proportion of cervical cancers since its introduction [ 4 ]. While widely recommended for detecting precancerous lesions [ 5 ], its effectiveness has been less pronounced in lower-income countries [ 6 ]. Reports from various regions illustrate disparate uptake rates, such as less than 5 percent in Uganda [ 7 ], around 31 percent in Jordan [ 8 ], approximately 27 percent in Malaysia [ 9 ], and 35 percent among Lebanese women [ 10 ].…”
Section: Background/introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…First, the non-response rate was high (approximately 50%), which might have resulted in non-response bias. Furthermore, biases such as response bias, recall bias, social or cultural acceptability, ambiguity about the performed test, and decreased inclusion of women from vulnerable groups may occur in survey-based studies [22]. These limitations can only be overcome by implementing high-quality data registration in a national cervical screening registry.…”
Section: Strengths and Limitations Of The Studymentioning
confidence: 99%
“…In Europe, screening and treating early neoplasia have substantially reduced the incidence and mortality of cervical cancer since 1960 [ 2 – 5 ]. In this area in 2021, rates of women aged 30–49 who reported ever having had a cervical cancer test varied from 42.0% (in Romania) to 98.4% in Finland, according to the WHO [ 6 ].In other high-income countries, rates were higher: 88% in the USA, 91% in Canada, and 95% in Australia had ever undergo Pap tests [ 7 ].…”
Section: Introductionmentioning
confidence: 99%